Delivery Order SPE2DB22D2007-SPE2DB25FJ5EL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $14,137.08. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is scheduled for ultimate completion on July 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Jardiance is a medication...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Jardiance 10 mg tablets in a 90-count package. This delivery order, valued at $26,553.55, represents a firm fixed-price contract with no set-aside designation, reflecting a competitively awarded procurement. The contract is scheduled for completion by September 4, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,364.00 to AmerisourceBergen Drug Corp for Jardiance 10 mg tablets (90-count packages) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, consistent...
- The Defense Logistics Agency awarded a delivery order valued at $3,143.74 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription diabetes medication commonly used in military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a ceiling value of $11,596.91. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under the company's existing indefinite delivery contract. The order is scheduled for completion by September 8, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $12,586.41 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 10, 2025, with an ultimate completion date of July 11, 2025. This firm fixed price delivery order represents a non-set-aside competitive award and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, aligning with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Jardiance 10 mg tablets (90-count packages) with a ceiling value of $16,657.53 under a firm fixed-price contract type. This is a non-set-aside competitive award, with performance to be completed by August 25, 2025, and fulfillment occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a contract ceiling value of $1,864.83. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by September 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Jardiance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Jardiance 25 mg tablets in a quantity of 90 units, with a ceiling value of $8,606.87. This competitively awarded delivery order utilizes firm fixed pricing and is scheduled for completion by August 18, 2025. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,001.08 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on June 2, 2025, with an ultimate completion date of June 3, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription medication commonly used in diabetes management,...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ5ELDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $46,182.60 under a firm fixed-price contract type. This is a competitively awarded, non-set-aside delivery order issued against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 23, 2025. Jardiance is a prescription medication used primarily for diabetes management, consistent with AmerisourceBergen's extensive portfolio of pharmaceutical products supplied to federal military and veteran healthcare systems. This delivery order represents a continuation of AmerisourceBergen's significant role as a pharmaceutical prime vendor for the Defense Logistics Agency. The company holds a $999.999 billion indefinite delivery contract (SPE2DX) with DLA Troop Support Medical extending through December 2026, which serves as the parent vehicle for this and numerous other delivery orders. AmerisourceBergen's federal contracting demonstrates consistent capability in fulfilling diverse pharmaceutical procurement needs across multiple therapeutic domains for military healthcare programs worldwide, positioning the company as a critical distributor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $46.2k | 9/22/25 |